Biomedical Systems Receives 510(k) Clearance from the FDA for TruVue™ Wireless Ambulatory ECG Monitoring System

The US Food and Drug Administration (FDA) has granted Biomedical Systems 510(k) clearance to market
TruVueâ„¢, a wireless ambulatory ECG monitoring system. TruVue is the industry's first cardiac Mobile
Telemetry system that analyzes, records and transmits every heart beat for up to 30 days.



                                                          TruVue combines automatic wireless data transmission and
                                                          sophisticated arrhythmia analysis to provide a comprehensive
                                                          long-term ECG monitoring solution for patients with existing
                                                          cardiac arrhythmia or those who may experience symptoms
                                                          suggestive of abnormal rhythm patterns. The transmitted
                                                          ECG is reviewed and validated by certified Biomedical Systems'
                                                          Cardiac Technicians and symptomatic patient events or
                                                          abnormal ECG findings are posted on-line immediately for
                                                          physician review.

                                                         To learn more about the future of wireless ambulatory ECG
                                                         monitoring, please click here.


GLOBAL OFFICES

 Corporate Headquarters
1 800 877 6334

 

Europe
+32 (0) 2 661 20 70

Japan
+81 29 886 7221

India
+91 413 22 22 016

                                


     

Biomedical Systems
 is now on
Twitter!